FY26 Preliminary Final Report
Filed with ASX · · 45 pages · English
Summary by 6ix AI
The report highlights a significant underlying loss after tax, although revenue from continuing operations showed a slight increase compared to the previous year. The company is focused on improving its pathology services and has implemented cost management strategies to enhance operational efficiency. Healius continues to invest in digital technologies to support productivity and service quality across its pathology network.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Healius
- Change of Director's Interest Notice - Paul Anderson
- Notification of cessation of securities - HLS
- 2026 AGM - Notification of dates
- Change of Share Registry Provider
- Webcast details for Healius FY26 Results
Later from Healius
- FY26 Results Release
- FY26 Results Presentation
- Application for quotation of securities - HLS
- Ceasing to be a substantial holder
- Change of Director's Interest Notice - Kathy Ostin
Follow Healius into a list and get an email when it puts out news.
Follow Healius